[
  {
    "ts": "2025-10-28T14:00:16+00:00",
    "headline": "Henry Schein (HSIC) Earnings Expected to Grow: Should You Buy?",
    "summary": "Henry Schein (HSIC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
    "url": "https://finance.yahoo.com/news/henry-schein-hsic-earnings-expected-140016605.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "1c0fac3f-a9fd-3c04-b457-0b33356e3ea4",
      "content": {
        "id": "1c0fac3f-a9fd-3c04-b457-0b33356e3ea4",
        "contentType": "STORY",
        "title": "Henry Schein (HSIC) Earnings Expected to Grow: Should You Buy?",
        "description": "",
        "summary": "Henry Schein (HSIC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
        "pubDate": "2025-10-28T14:00:16Z",
        "displayTime": "2025-10-28T14:00:16Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/f541c90e0d995722d10914cb76a7c653",
          "originalWidth": 900,
          "originalHeight": 600,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/0sIIP41M0Yl73BbPadjNMg--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/f541c90e0d995722d10914cb76a7c653.cf.webp",
              "width": 900,
              "height": 600,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/WsNU52Eg.hsicG83rNZXgw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/f541c90e0d995722d10914cb76a7c653.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/henry-schein-hsic-earnings-expected-140016605.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/henry-schein-hsic-earnings-expected-140016605.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "HSIC"
            },
            {
              "symbol": "CAH"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-28T13:15:06+00:00",
    "headline": "Cardinal (CAH) Q1 Earnings on the Horizon: Analysts' Insights on Key Performance Measures",
    "summary": "Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Cardinal (CAH), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2025.",
    "url": "https://finance.yahoo.com/news/cardinal-cah-q1-earnings-horizon-131506685.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "8afdbeca-091d-3132-b94b-0a3a51a30f8e",
      "content": {
        "id": "8afdbeca-091d-3132-b94b-0a3a51a30f8e",
        "contentType": "STORY",
        "title": "Cardinal (CAH) Q1 Earnings on the Horizon: Analysts' Insights on Key Performance Measures",
        "description": "",
        "summary": "Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Cardinal (CAH), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2025.",
        "pubDate": "2025-10-28T13:15:06Z",
        "displayTime": "2025-10-28T13:15:06Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/4f1a8d86cead9f96536efb147945dcc9",
          "originalWidth": 900,
          "originalHeight": 565,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/YtAJ1dNJrNLDESvqOxl.SQ--~B/aD01NjU7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/4f1a8d86cead9f96536efb147945dcc9.cf.webp",
              "width": 900,
              "height": 565,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/G.P5BxCVxDtGSv3VMOFVgA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/4f1a8d86cead9f96536efb147945dcc9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/cardinal-cah-q1-earnings-horizon-131506685.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/cardinal-cah-q1-earnings-horizon-131506685.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CAH"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-28T12:05:00+00:00",
    "headline": "United State Cell and Gene Therapy Third-Party Logistics Market Analysis Report 2025-2033: Expansion Fueled by Rising R&D Expenditure, Regulatory Complexity, & Strong Demand from Major Biopharma Hubs",
    "summary": "The U.S. Cell and Gene Therapy Third-Party Logistics (3PL) Market is anticipated to surge from US$ 2.61 billion in 2024 to US$ 5.88 billion by 2033, maintaining a CAGR of 9.46% from 2025 to 2033. Key growth drivers include increased therapy adoption, specialized logistics needs, and expanding biopharmaceutical collaborations. Regulatory demands, cold chain technology adoption, and challenges such as logistics costs and workforce expertise underscore the market's evolution. States like California",
    "url": "https://finance.yahoo.com/news/united-state-cell-gene-therapy-120500619.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "f77542e8-bf73-38b2-90f7-e118b2f93933",
      "content": {
        "id": "f77542e8-bf73-38b2-90f7-e118b2f93933",
        "contentType": "STORY",
        "title": "United State Cell and Gene Therapy Third-Party Logistics Market Analysis Report 2025-2033: Expansion Fueled by Rising R&D Expenditure, Regulatory Complexity, & Strong Demand from Major Biopharma Hubs",
        "description": "",
        "summary": "The U.S. Cell and Gene Therapy Third-Party Logistics (3PL) Market is anticipated to surge from US$ 2.61 billion in 2024 to US$ 5.88 billion by 2033, maintaining a CAGR of 9.46% from 2025 to 2033. Key growth drivers include increased therapy adoption, specialized logistics needs, and expanding biopharmaceutical collaborations. Regulatory demands, cold chain technology adoption, and challenges such as logistics costs and workforce expertise underscore the market's evolution. States like California",
        "pubDate": "2025-10-28T12:05:00Z",
        "displayTime": "2025-10-28T12:05:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/5e0e59a4c1355db59ce69e12961315af",
          "originalWidth": 600,
          "originalHeight": 400,
          "caption": "U.S. Cell and Gene Therapy Third-Party Logistics Market",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Gd02Q62I4kx6uzzjEjhRUg--~B/aD00MDA7dz02MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/5e0e59a4c1355db59ce69e12961315af.cf.webp",
              "width": 600,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/sWAcVguhGimuONlY8rnVCQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/5e0e59a4c1355db59ce69e12961315af.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/united-state-cell-gene-therapy-120500619.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/united-state-cell-gene-therapy-120500619.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "COR"
            },
            {
              "symbol": "CAH"
            },
            {
              "symbol": "MCK"
            },
            {
              "symbol": "DHL.DE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]